Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | DHODH | Q02127 | 5/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Carfentrazone-Ethyl SCHEMBL7582568 | 0.94 | MAPT (0.31) | MAPTMEN1ALDH1A1KMT2ASMN1; SMN2 | |
| Carfentrazone-Ethyl SCHEMBL7589892 | 0.92 | MAPT (0.31) | MAPT | |
| Carfentrazone-Ethyl SCHEMBL7582698 | 0.91 | MAPT (0.30) | MAPT | |
| Carfentrazone-Ethyl SCHEMBL7585688 | 0.90 | MAPT (0.40) | MAPTMEN1ALDH1A1KMT2ASMN1; SMN2 | |
| Carfentrazone-Ethyl SCHEMBL7579240 | 0.90 | — | — | |
| Carfentrazone-Ethyl SCHEMBL7588086 | 0.89 | TP53 (0.37) | DHODH | |
| Carfentrazone-Ethyl SCHEMBL7585700 | 0.89 | TP53 (0.40) | MEN1ALDH1A1KMT2ADHODH | |
| Carfentrazone-Ethyl SCHEMBL7590296 | 0.87 | — | — | |
| Carfentrazone-Ethyl SCHEMBL7581812 | 0.87 | MAPT (0.36) | MAPTMEN1ALDH1A1KMT2ASMN1; SMN2 | |
| Carfentrazone-Ethyl SCHEMBL7582961 | 0.86 | DHODH (0.30) | DHODH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020004457-A1 | Herbicidal composition | SYNGENTA PARTICIPATIONS AG (CH) | 2002-01-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020004457-A1 | Herbicidal composition | PPOX, ALAD, DDT | MAPT 1092/4885MEN1 4274/4885ALDH1A1 812/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.